Conversion optimization and experimentation

Control group

Quick definition

A control group is a comparison group used to estimate what would happen without the particular change being tested. In a marketing experiment, the treatment group receives an intervention while the control group receives a defined alternative, such as the existing experience or no additional campaign. Comparing outcomes helps assess the intervention's effect. The control is not necessarily inactive: customers may still see the normal website, receive routine service, or encounter other marketing. What matters is a clear difference in the tested treatment and a design that makes the groups meaningfully comparable. Random assignment is often used to reduce systematic differences at the start. A control group supports causal learning when the experiment is designed and analyzed appropriately; merely naming one audience “control” does not make a comparison reliable.

Define the question and the counterfactual

Specify the action being tested, the eligible population, the outcome, and the observation period. Explain what the control group will experience and why it represents the relevant alternative. A fictional retailer testing a cart reminder might compare eligible shoppers who receive the reminder with eligible shoppers who do not, while both groups retain normal access to the store. A website experiment might compare a new form with the current form rather than withholding the form entirely. The alternative should match the decision the team needs to make. Testing a discount against no communication answers a different question from testing the discount against a helpful non-discounted reminder. Clear definitions prevent the experiment from producing a technically precise answer to a question that does not resolve the actual business choice.

Assign groups at the right level

Choose an assignment unit that fits how the treatment operates and how people can influence each other. Individuals, households, accounts, stores, or geographic areas may be appropriate in different situations. Keep assignment stable so the same participant does not repeatedly move between treatment and control during the test. Randomization can make groups comparable on average, but small samples can still differ by chance. Important design choices may require stratification or other specialist planning. Avoid comparing a hand-picked high-intent treatment audience with a broad lower-intent control and attributing the difference to the campaign. Consider whether people in one group can share the treatment with people in the other. For example, account-level buying decisions may be affected by several employees, making individual assignment unsuitable for some business-to-business interventions.

Protect the intended comparison during delivery

Check that treatment is delivered as planned and that the control is not accidentally exposed through another workflow. A fictional email test can be compromised if a separate automation sends the same offer to held-out customers. Coordinate relevant teams, systems, and suppression rules before launch. Keep other major changes consistent across groups where practical, and document deviations that cannot be avoided. Monitor implementation without repeatedly changing the experiment to chase early results. Missing data, broken links, or unequal measurement can undermine the comparison even when assignment was sound. Define how eligibility changes and technical failures will be handled in the analysis. The goal is not a perfectly isolated world, but a dependable difference in the tested intervention with enough documentation to interpret what participants actually experienced.

Calculate the effect and its uncertainty

Suppose a fictional experiment assigns 1,000 eligible customers to each group. Eighty treatment customers purchase and sixty control customers purchase during the same window. The observed purchase rates are 8% and 6%, giving an absolute difference of two percentage points. Relative to the 6% control rate, that is approximately a 33.3% increase. The treatment group has twenty more observed purchases, but the estimate still has sampling uncertainty. Do not assume a positive difference proves a durable effect or that all eighty treatment purchases were caused by the intervention. Assess uncertainty using an analysis appropriate to the design and outcome. Translate the effect into business value with relevant costs, refunds, and margins, rather than stopping at a favorable percentage that may not justify the intervention economically.

Interpret results within the experiment's limits

Report the population, treatment, control condition, duration, outcome definition, and important deviations alongside the result. Distinguish evidence of little effect from an inconclusive test that lacks precision. A result from existing customers during a sale may not generalize to new prospects or ordinary weeks. Consider delayed outcomes and unintended effects such as complaints, returns, or reduced future purchasing. Avoid extending the experiment only until the preferred result appears unless the design explicitly supports the chosen monitoring method. Use the findings to make the defined decision, then identify what remains uncertain. A well-run control comparison can reveal that an apparently successful campaign mainly captured purchases that would have happened anyway. That is useful learning, even when it challenges an attractive attribution report or an enthusiastic launch narrative.

Frequently asked questions

Does a control group receive no marketing at all?

Not necessarily. It receives the defined comparison condition, which may include normal business activity while excluding only the tested intervention. Document that condition clearly. If the question concerns an extra reminder, the control may still receive routine communications. The experiment estimates the effect of the specific difference between groups, not automatically the effect of every marketing activity combined.

Must the control group be the same size as the treatment group?

No. Equal allocation is common, but different ratios can be appropriate depending on costs, risks, expected effects, and statistical planning. The choice affects precision and resource use. Decide the allocation before launch with the experiment's requirements in mind. Do not reduce the control simply because withholding treatment feels inconvenient if doing so makes the comparison too imprecise to answer the question.

Can last month's customers serve as a control group?

A historical comparison can provide context, but it is not equivalent to a concurrently randomized control. Seasonality, audience composition, pricing, competition, and other conditions may have changed. If a historical design is used, examine those differences and describe its limitations. Avoid treating a before-and-after increase as proof that the new activity caused the change.

What if the treatment performs worse than the control?

Investigate whether the result is sufficiently precise and whether implementation worked as intended. A real negative effect may show that the intervention adds friction, attracts poor-quality demand, or creates unwanted consequences. Do not dismiss it solely because the idea seemed promising. Use the evidence to stop, revise, or narrow the approach, and preserve the learning for future decisions.

Related terms

  • A/B testing: A common experimental approach comparing alternatives, often using an existing version as the control condition.
  • Incrementality: The additional effect of an intervention, which a well-designed control comparison can help estimate.
  • Conversion: The defined action measured across groups, requiring consistent collection and an appropriate observation period.
  • Statistical significance: An inferential concept that must be interpreted alongside effect size, uncertainty, and the quality of the experiment.
  • Sample size: The amount of evidence available, influencing the precision with which differences between groups can be estimated.
  • Return on ad spend: A revenue-to-spend ratio that can describe attributed results but does not by itself establish the additional effect measured by a control comparison.